Health TrialsbyHealthPanel

Hepatitis C Tracker Study

ConditionHepatitis C Virus Infection
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Southern California

About this trial

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing unsheltered homelessness and receiving street medicine. Research will compare medication adherence among participants randomly assigned to receive standard medical care for Hepatitis C versus the standard medical care for Hepatitis C along with GPS tracking assistance.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosed with Hepatitis C infection

Experiencing unsheltered homelessness at study initiation

Speaks English or Spanish

Receiving street medicine care

Disqualifiers

Prior engagement in HCV treatment

Decompensated cirrhosis; HBsAg positive

Current pregnancy; Known or suspended hepatocellular carcinoma

Prior liver transplantation

Trial design

Design model

Parallel

Treatments tested in this trial

  • GPS tracker device

    Behavioral

    GPS tracker device

Treatment groups

124 Participants
are divided into 2 treatment groups
Group A: Standard HCV treatmentNo intervention 0 interventions
Group B: Standard HCV treatment + GPS tracker deviceActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Medication Adherence Rate

Number of prescribed HCV pills taken (missing from pill organizer) versus number of HCV pills prescribed (present in pill organizer) per week, for each week of the 12-week treatment regimen

Time frame
8-12 weeks
2

Length of treatment course

Number of weeks patient engaged in HCV medication treatment

Time frame
8-12 weeks

Secondary outcomes

1

Sustained virologic response

"Undetectable" quantitative HCV RNA blood value 12-weeks post conclusion of HCV treatment course

Time frame
through study completion, an average of 24 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Southern California

Lead sponsor

Ventura County Medical Center

Collaborator

Source ClinicalTrials.gov
Apply now